agar and 5-bromo-4-chloro-3-indolyl-beta-galactoside

Although blue-white screening based on α-complementation has been widely used in the screening of genetically modified bacteria, only a single blue-white screening is typically not enough to eliminate false positives. Sometimes, a secondary blue-white screening for the target colonies is required. In this study, two methods were used to investigate the feasibility of secondary blue-white screening for target colonies on lysogeny broth (LB)-ampicillin agar plates. The first method consisted of covering the target colonies grown on LB-ampicillin plate medium with a sterilized filter paper soaked in a solution of 60 μL 20 mg/mL X-gal and 8 μL 20% IPTG. The second method was that blue and white colonies were randomly selected from the blue-white screening plate medium and then re-streaked onto the blue-white screening medium. The colonies were then treated by two methods and incubated at 37°C for 12 h. The results showed that some of the white colonies treated by the two methods showed results similar to the colonies grown on the blue-white screening medium. These results indicate that the target colonies grown on blue-white screening medium can still be used to carry out a secondary blue-white screening. Thus, a blue-white screening liquid was successfully developed. Using the blue-white screening liquid, false positives can be eliminated directly based on the color of the target colonies. This will greatly improve the screening efficiency of positive clones and has important practical implications.

Topics: Agar; Bacteria; Colony Count, Microbial; Culture Media; Galactosides; Genetic Engineering; Indoles; Isopropyl Thiogalactoside

Several outbreaks of foodborne yersiniosis have been documented and this disease continues to be source of infections transmitted through foods. The selective agars most commonly used to isolate Yersinia enterocolitica in clinical, food and environmental samples, cefsulodin-irgasan-novobiocin (CIN) and MacConkey (MAC) agars, lack the ability to differentiate potentially virulent Y. enterocolitica from other Yersinia that may be present as well as some other bacterial spp. This study proposes the use of an agar medium, Y. enterocolitica chromogenic medium (YeCM), for isolation of potentially virulent Y. enterocolitica. This agar contains cellobiose as the fermentable sugar, a chromogenic substrate and selective inhibitors for suppression of colony formation by many competing bacteria. All strains of potentially virulent Yersinia of biotypes 1B, and biotypes 2-5 formed convex, red bulls-eye colonies on YeCM that were very similar to those described for CIN agar. However, Y. enterocolitica biotype 1A and other related Yersinia formed colonies that were purple/blue on YeCM while they formed typical red bulls-eye colonies on CIN agar. When a mixture of potentially virulent Y. enterocolitica biotype 1B, Y. enterocolitica biotype 1A and 5 other bacterial species was used to artificially contaminate tofu and then spread-plated on three selective agars, Y. enterocolitica biotype 1B colonies were easily distinguished from other strains on YeCM. However, Y. enterocolitica biotype 1B colonies were indistinguishable from many other colonies on CIN and only distinguishable from those of C. freundii on MAC. When colonies were picked and identified from these agars, typical colonies from YeCM were confirmed only as Y. enterocolitica biotype 1B. Typical colonies on CIN and MAC were found to belong to several competing species and biotypes.

Topics: Agar; Bacterial Typing Techniques; Cellobiose; Chromogenic Compounds; Culture Media; Galactosides; Humans; Indoles; Virulence; Yersinia enterocolitica

Salmonella chromogenic medium (SCM; Oxoid, Basingstoke, United Kingdom), a new selective chromogenic medium, was compared to DCLS agar (Oxoid) for the detection and presumptive identification of Salmonella species from stool samples. This medium contains two chromogenic substrates, Magenta-cap (5-bromo-6-chloro-3-indolylcaprylate), which is hydrolyzed by Salmonella species to give magenta colonies, and X-Gal (5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside), which is incorporated to visualize beta-D-galactosidase-producing organisms as blue colonies. Thus, non-Salmonella organisms appear blue or are not stained by any of the chromogens of the medium. A total of 500 stool samples were investigated by plating them directly and after selenite enrichment on DCLS agar and SCM. A total of 44 Salmonella-positive stool samples were detected. The sensitivities for direct plating and after enrichment were 22.7 and 81.8%, respectively, for DCLS agar, and for SCM these values were 34.1 and 100%, respectively. The specificities for direct plating and after enrichment were 82.5 and 72.8%, respectively, for DCLS agar and 98.5 and 95.8%, respectively, for SCM. According to these results, the sensitivities of SCM and DCLS agar were comparable on primary plating. However, the sensitivity of SCM was significantly higher after enrichment. In addition, the specificity of SCM was also significantly higher than that of DCLS agar both before and after enrichment. On the basis of these results, SCM can be recommended for the isolation of Salmonella species from stool samples in preference to DCLS agar.

Topics: Agar; Bacteriological Techniques; Chromogenic Compounds; Culture Media; Feces; Galactosides; Humans; Indoles; Rosaniline Dyes; Salmonella; Salmonella Infections; Sensitivity and Specificity

A lambda/lacI shuttle vector transgenic mouse mutagenesis assay has been optimized and standardized for reproducible mutant detection. The mutagenic endpoints are blue lacI- phage plaques on a bacterial lawn resulting from the de-repression of beta-galactosidase activity acting on the chromogenic substrate X-gal. Non-mutant lacI phage plaques remain colorless. Factors demonstrated to affect mutant detection include X-gal concentration per assay tray, plaque density per assay tray, pH of plating agar, incubation time at 37 degrees C and the use of a red translucent screening filter over a light source to enhance mutant plaque visibility. In vivo mutant frequencies for liver in untreated animals using standard protocols and internal controls were repeatable in separate experiments using lambda/lacI B6C3F1 mice (4.3 +/- 1.2 x 10(-5) and 4.1 +/- 0.8 x 10(-5)). These studies analyze the use of internal controls to monitor the level of mutant phage plaque detection in a given experiment and evaluate the repeatability of observed mutant frequencies obtained when using standardized procedures.

Topics: Agar; Animals; Bacterial Proteins; Bacteriophage lambda; beta-Galactosidase; Chromogenic Compounds; DNA, Recombinant; Enzyme Induction; Escherichia coli; Escherichia coli Proteins; Female; Galactosides; Gene Expression Regulation, Bacterial; Genes, Reporter; Genes, Synthetic; Genetic Vectors; Hydrogen-Ion Concentration; Indoles; Lac Repressors; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutagenicity Tests; Recombinant Fusion Proteins; Repressor Proteins; Reproducibility of Results; Viral Plaque Assay